All In Biotech

Free tool

FAERS Monitor: Avalide

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020758 or its brand name (Avalide, Hydrochlorothiazide, Irbesartan). Reports on generic versions are filed under their own applications.

Reports

5,317

Serious

3,023

57% of reports

Hospitalization

1,525

Death reported

277

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea352
  • dizziness338
  • fatigue308
  • drug ineffective298
  • dyspnoea246
  • headache244
  • blood pressure increased217
  • diarrhoea216
  • hypertension202
  • pain195
  • vomiting192
  • asthenia186
  • fall174
  • pain in extremity172
  • arthralgia164

Reports by year received

View as table
YearReports
2004198
2005271
2006304
2007310
2008351
2009400
2010475
2011742
2012402
2013174
2014165
2015175
2016188
2017137
2018182
2019252
2020128
202199
2022113
202373
202474
202565
202639

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,842 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure increasedSignal2175.64.9825
hypertensionSignal2023.83.3413
dizzinessSignal3382.72.4363
pain in extremitySignal1722.32.0128
fallSignal1742.11.896
asthenia1862.01.788
nausea3521.81.6119
dyspnoea2461.71.575
vomiting1921.61.445
fatigue3081.61.465
arthralgia1641.61.333
headache2441.51.447
diarrhoea2161.31.217
pain1951.31.110
drug ineffective2980.90.84

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.